AJP - Lung Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (December 13, 2002). doi:10.1152/ajplung.00324.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/4/L599    most recent
00324.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (41)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tilley, S. L.
Right arrow Articles by Koller, B. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tilley, S. L.
Right arrow Articles by Koller, B. H.

Articles in PresS, published online ahead of print December 13, 2002
Am J Physiol Lung Cell Mol Physiol, 10.1152/ajplung.00324.2002
Submitted on September 26, 2002
Accepted on December 4, 2002

Receptors and pathways mediating the effects of prostaglandin E2 on airway tone

Stephen L. Tilley1, John M. Hartney2, Christopher J. Erikson1, Corey Jania1, MyTrang Nguyen2, Jeffrey Stock3, John McNeisch3, Cathy Valancius4, Reynold A. Panettieri, Jr.5, Raymond B. Penn4, and Beverly H. Koller6*

1 Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, N.C., USA
2 Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, N.C., USA
3 Genetic Technologies, Pfizer global research and development, Groton, C.T., USA
4 Department of Medicine, Thomas Jefferson University, Chapel Hill, N.C., USA
5 Department of Medicine, University of Pennsylvania, Chapel Hill, N.C., USA
6 Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, N.C., USA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, N.C., USA

* To whom correspondence should be addressed. E-mail: treawouns{at}aol.com.

Prostaglandin E2 (PGE2) has complex effects on airway tone and the existence of four PGE2 (EP) receptors, each with distinct signaling characteristics, has provided a possible explanation for the seemingly contradictory actions of this lipid mediator. To identify the receptors mediating the actions of PGE2 on bronchomotor tone, we examined its effects on the airways of wild type and EP receptor deficient mice. In conscious mice the administration of PGE2 increased airway responsiveness primarily through the EP1 receptor, although on certain genetic backgrounds a contribution of the EP3 receptor was detected. These effects of PGE2 were eliminated by pre-treatment with either atropine or bupivacaine, and were undetectable in anesthetized mice or in dennervated tracheal rings, where only EP2-mediated relaxation of airway smooth muscle was observed. Taken together, our findings are consistent with a model in which PGE2 modulates airway tone by activating multiple receptors expressed on various cell populations and in which the relative contribution of these receptors might depend on the expression of modifier alleles. PGE2/EP1/EP3-induced airway constriction occurs indirectly through activation of neural pathways, while PGE2-induced bronchodilation results from direct activation of EP2 receptors on airway smooth muscle. This segregation of EP receptor function within the airway suggests that PGE2 analogues that selectively activate the EP2 receptor without activating the EP1/EP3 receptors might prove useful in the treatment of asthma.




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
S. A. Maher, M. A. Birrell, and M. G. Belvisi
Prostaglandin E2 Mediates Cough via the EP3 Receptor: Implications for Future Disease Therapy
Am. J. Respir. Crit. Care Med., November 15, 2009; 180(10): 923 - 928.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
L. Swedin, T. Neimert-Andersson, J. Hjoberg, S. Jonasson, M. van Hage, M. Adner, A. Ryrfeldt, and S-E. Dahlen
Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice
Eur. Respir. J., July 1, 2009; 34(1): 200 - 208.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Y. C. Ruan, Z. Wang, J. Y. Du, W. L. Zuo, J. H. Guo, J. Zhang, Z. L. Wu, H. Y. Wong, Y. W. Chung, H. C. Chan, et al.
Regulation of smooth muscle contractility by the epithelium in rat vas deferens: role of ATP-induced release of PGE2
J. Physiol., October 15, 2008; 586(20): 4843 - 4857.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Testa, B. Rocca, L. Spath, F. O. Ranelletti, G. Petrucci, G. Ciabattoni, F. Naro, S. Schiaffino, M. Volpe, and C. Reggiani
Expression and activity of cyclooxygenase isoforms in skeletal muscles and myocardium of humans and rodents
J Appl Physiol, October 1, 2007; 103(4): 1412 - 1418.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
X. Hua, C. J. Erikson, K. D. Chason, C. N. Rosebrock, D. A. Deshpande, R. B. Penn, and S. L. Tilley
Involvement of A1 adenosine receptors and neural pathways in adenosine-induced bronchoconstriction in mice
Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L25 - L32.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
G. L. Larsen, J. Loader, C. Fratelli, J.-k. B. Kang, A. Dakhama, and G. N. Colasurdo
Modulation of airway responses by prostaglandins in young and fully grown rabbits
Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L239 - L244.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. J. Canning
Reflex regulation of airway smooth muscle tone
J Appl Physiol, September 1, 2006; 101(3): 971 - 985.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. Borger, M. Tamm, J. L. Black, and M. Roth
Asthma: Is It Due to an Abnormal Airway Smooth Muscle Cell?
Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 367 - 372.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
B. Rocca
Targeting PGE2 Receptor Subtypes Rather Than Cyclooxygenases: A Bridge Over Troubled Water?
Mol. Interv., April 1, 2006; 6(2): 68 - 73.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. C. Allen, J. M. Hartney, T. M. Coffman, R. B. Penn, J. Wess, and B. H. Koller
Thromboxane A2 induces airway constriction through an M3 muscarinic acetylcholine receptor-dependent mechanism
Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L526 - L533.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. M. Hartney, K. G. Coggins, S. L. Tilley, L. A. Jania, A. K. Lovgren, L. P. Audoly, and B. H. Koller
Prostaglandin E2 protects lower airways against bronchoconstriction
Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L105 - L113.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Tanaka, S. Kanako, and S. Abe
Prostaglandin E2 Receptor Selective Agonists E-Prostanoid 2 and E-Prostanoid 4 May Have Therapeutic Effects on Ovalbumin-Induced Bronchoconstriction
Chest, November 1, 2005; 128(5): 3717 - 3723.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
K. F. Chung
Evaluation of Selective Prostaglandin E2 (PGE2) Receptor Agonists as Therapeutic Agents for the Treatment of Asthma
Sci. Signal., September 27, 2005; 2005(303): pe47 - pe47.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2002 by the American Physiological Society.